WCN25-4532 BALANCING EFFICACY, QUALITY OF LIFE, AND COST-EFFECTIVENESS: A COMPARATIVE STUDY OF DESIDUSTAT AND ERYTHROPOIETIN IN CHRONIC KIDNEY DISEASE PATIENTS ON HEMODIALYSIS

WCN25-4532 BALANCING EFFICACY, QUALITY OF LIFE, AND COST-EFFECTIVENESS: A COMPARATIVE STUDY OF DESIDUSTAT AND ERYTHROPOIETIN IN CHRONIC KIDNEY DISEASE PATIENTS ON HEMODIALYSIS

Saved in:

Bibliographic Details
Main Authors:	Y. Dharanidhar Reddy, Indhumathi elayaperumal
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924023702
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN25-2178 GERIATRIC ASSESSMENT AND NUTRITIONAL STATUS OF ELDERLY PATIENTS (AGE>65 YEARS) ON HEMODIALYSIS FROM A TERITIARY CARE CENTRE IN SOUTH INDIA
by: SAJMI SHAJI, et al.
Published: (2025-02-01)

WCN25-3673 CHRONIC HEMODIALYSIS: A UNIQUE CHALLENGE TO WOMEN’S BONE HEALTH, MENSTRUAL DISTURBANCES AND ITS ASSOCIATION WITH HYPERPROLACTINEMIA, NUTRITIONAL AND MENTAL STATUS, AND THEIR IMPACT ON QUALITY OF LIFE - A PROSPECTIVE OBSERVATIONAL STUDY
by: Elayaperumal Indhumathi, et al.
Published: (2025-02-01)

WCN25-4361 COMPARING DESIDUSTAT – A HYPOXIA INDUCIBLE FACTOR STABILIZER AND ERYTHROPOIETIN STIMULATING AGENTS IN TREATMENT OF ANEMIA IN HEMODIALYSIS DEPENDANT CHRONIC KIDNEY DISEASE
by: abhishek mistry, et al.
Published: (2025-02-01)

WCN25-4211 A COMPARATIVE STUDY OF DESIDUSTAT AND ERYTHROPOIETIN STIMULATING AGENTS IN CKD-RELATED ANEMIA
by: Gaurav Modi, et al.
Published: (2025-02-01)

WCN25-4212 THE IMPACT OF RHABDOMYOLYSIS INDUCED AKI ON PATIENT OUTCOMES
by: k sai sindhu singh, et al.
Published: (2025-02-01)

WCN25-1678 HIGH DOSE ERYTHROPOIETIN VERSUS DESIDUSTAT FOR TREATMENT OF ANEMIA IN PATIENTS OF CHRONIC KIDNEY DISEASE HAVING INADEQUATE RESPONSE TO WEIGHT BASED ERYTHROPOIETIN DOSE: PROSPECTIVE OBSERVATIONAL STUDY
by: Smita Divyaveer, et al.
Published: (2025-02-01)

WCN24-1337 OUTCOME OF CUFFED TUNNELED DIALYSIS CATHETER AS AN ACCESS FOR HEMODIALYSIS: A SINGLE CENTRE EXPERIENCE FROM A TERTIARY CARE CENTRE IN SOUTH INDIA
by: YDHARANIDHAR REDDY, et al.
Published: (2024-04-01)

WCN25-4457 BEVEL INSERTION IN AVF PAIN
by: Manodhar Vunnam, et al.
Published: (2025-02-01)

WCN25-4372 A PROSPECTIVE, SINGLE-CENTRE STUDY ON THE EFFICACY AND SAFETY OF DESIDUSTAT IN CHRONIC KIDNEY DISEASE-INDUCED ANEMIA
by: Prof (Dr ) Sanjeev Gulati, et al.
Published: (2025-02-01)

WCN25-84 ROLE OF DESIDUSTAT IN ANEMIC CKD-EASTERN INDIA EXPERIENCE
by: Rohit Rungta
Published: (2025-02-01)

WCN25-4241 CENTRAL VEIN STENOSIS -CLINICAL PRESENTATION ,INTERVENTION AND OUTCOME AT OUR CENTRE
by: Chakradhar Arepalli, et al.
Published: (2025-02-01)

WCN25-4285 A RETROSPECTIVE STUDY ON THE OUTCOMES OF DESIDUSTAT IN CHRONIC KIDNEY DISEASE PATIENTS WITH ANEMIA: A SINGLE CENTRE EXPERIENCE
by: Tejaswi Kolli, et al.
Published: (2025-02-01)

WCN25-3769 CORRECTION OF FUNCTIONAL IRON DEFICIENCY AND IRON SEQUESTRATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE WITH DESIDUSTAT: A RETROSPECTIVE STUDY
by: Sourabh Gupta, et al.
Published: (2025-02-01)

WCN25-2485 REAL-WORLD EXPERIENCE OF DESIDUSTAT IN CKD-ANEMIA PATIENTS: DATA FROM NORTHEAST INDIA
by: Karan Saraf
Published: (2025-02-01)

WCN25-2314 EFFICACY OF DESIDUSTAT IN FUNCTIONAL IRON DEFICIENCY ANAEMIA IN DIALYSIS-DEPENDENT CKD PATIENTS WITH ELEVATED FERRITIN: A SINGLE-CENTRE STUDY
by: Rajeev Kumar Bhatia, et al.
Published: (2025-02-01)

WCN25-661 Switching Strategies: Evaluating the Safety and Efficacy of Non-Steroidal Mineralocorticoid Antagonists (ns MRA) in Spironolactone- non tolerant Post-Transplant Recipients
by: Chakradhar Arepalli, et al.
Published: (2025-02-01)

WCN25-2158 DESIDUSTAT IN ERYHTROPOETIN INDUCED PURE RED CELL APLASIA IN DIALYSIS-DEPENDENT CKD PATIENTS: A CASE REPORT
by: Arun Shah, et al.
Published: (2025-02-01)

WCN25-2135 REAL-WORLD EXPERIENCE OF DESIDUSTAT IN CKD PATIENTS WITH ANEMIA: A SINGLE CENTRE, OPEN LABEL, OBSERVATIONAL STUDY
by: Prashant Bendre
Published: (2025-02-01)

WCN25-2356 REAL WORLD EXPERIENCE OF HIF-PHI – DESIDUSTAT (OXEMIA®) IN DIALYSIS AND NON-DIALYSIS DEPENDENT CKD ANEMIA PATIENTS
by: Vijay Sinha, et al.
Published: (2025-02-01)

WCN25-1035 Association between Anti-Erythropoietin Receptor Antibodies and Cardiac Function in Patients on Hemodialysis: A Multi-center Cross-Sectional Study
by: Yasuhiro Mochida, et al.
Published: (2025-02-01)

Efficacy of L-carnitine combined with erythropoietin in the treatment of hemodialysis-induced renal anemia
by: ZHANG Yong, et al.
Published: (2018-01-01)

WCN24-1362 RISK FACTORS INVOLVED IN ERYTHROPOIETIN RESISTANCE IN PATIENTS WITH CKD IN A HEMODIALYSIS UNIT
by: Enrique Fleuvier Morales López, et al.
Published: (2024-04-01)

WCN25-2867 In Vitro Response of UT-7 Cell Line to Erythropoietin-Resistant and Erythropoietin-Responsive Serum from Hemodialysis Patients in Addington & King Edward VIII Hospitals, KwaZulu Natal- South Africa
by: Sherilene Cheryl Benjamin, et al.
Published: (2025-02-01)

WCN24-1670 ACHIEVING PLASTIC NEUTRALITY IN PERITONEAL DIALYSIS: A STEP TOWARDS SUSTAINABLE KIDNEY CARE
by: Y.DHARANIDHAR REDDY, et al.
Published: (2024-04-01)

WCN25-2264 ONE-YEAR RETROSPECTIVE ANALYSIS OF DESIDUSTAT: A PROMISING HIF-PHI FOR ANEMIA MANAGEMENT IN DIALYSIS-DEPENDENT CKD PATIENTS
by: Rajeev Kumar Bhatia, et al.
Published: (2025-02-01)

WCN25-4053 A CASE SERIES OF POST TRANSPLANT - PARVOVIRUS B19 INDUCED ANAEMIA TREATED WITH NOVEL HIF-PHI: DESIDUSTAT
by: Sreedhar CG, et al.
Published: (2025-02-01)

WCN24-926 A real-world experience of Desidustat in Chronic Kidney Disease-anemia patients: A single centre experience
by: Rohit Rungta
Published: (2024-04-01)

WCN25-1401 COST UTILITY ANALYSIS COMPARING EXPANDED AND HIGH-FLUX HEMODIALYSIS
by: Angela Rivera, et al.
Published: (2025-02-01)

WCN25-1198 PROSPECTIVE STUDY COMPARING EFFICACY AND COST EFFECTIVENESS OF HEMODIAFILTRATION VS CONVENTIONAL HEMODIALYSIS IN A TERTIARY CARE CENTRE
by: B Dushyanth, et al.
Published: (2025-02-01)

WCN25-2605 QUALITY OF LIFE, CARE GIVER BURDEN AND COST - COMPARISON BETWEEN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS AND HEMODIALYSIS
by: Sumathi G, et al.
Published: (2025-02-01)

WCN25-3701 THE DESTINY OF END-OF-LIFE HEMODIALYSIS MACHINES: AN INTERNATIONAL SURVEY
by: Andrew Davenport, et al.
Published: (2025-02-01)

WCN25-1595 ORAL HEALTH ASSESSMENT IN CHRONIC KIDNEY DISEASE (CKD) PATIENTS ON MAINTENANCE HEMODIALYSIS
by: Akash Rana, et al.
Published: (2025-02-01)

WCN25-861 Prevalence and clinical spectrum of Tuberculosis in End stage kidney disease patients on hemodialysis
by: Saurabh Puri, et al.
Published: (2025-02-01)

WCN25-4281 Resistant Hypertension and Contributing Factors in Regular Hemodialysis Patients in Rasyida Kidney Hospital
by: Bayu Rusfandi, et al.
Published: (2025-02-01)

WCN25-4439 ARE THESE WHEALS FOR REAL? A HEMODIALYSIS PATIENT WITH URTICARIA AT THE START OF HEMODIALYSIS
by: Manal Al Senaidi, et al.
Published: (2025-02-01)

WCN24-934 Retrospective analysis of Desidustat in CKD patients with anemia – A single center experience from India
by: Sanjeev Kumar Hiremath, et al.
Published: (2024-04-01)

Clinical efficacy and safety analysis in initial hemodialysis patient with renal anemia treated by roxadustat or recombinant human erythropoietin
by: Zhang Peng-jie, et al.
Published: (2022-11-01)

WCN25-920 GUNSHOT WOUND IN ARTERIOVENOUS FISTULA FOR HEMODIALYSIS
by: ROBERTO RAMIREZ MARMOLEJO, et al.
Published: (2025-02-01)

WCN25-1010 ASSESSMENT OF PHYSICAL FUNCTIONING IN HEMODIALYSIS PATIENTS
by: Konstantin Vishnevskii, et al.
Published: (2025-02-01)

WCN25-1089 THE USE OF ACETAMINOPHEN FOR PAIN RELIEF IN PATIENTS WITH STAGE 5 CHRONIC KIDNEY DISEASE ON HEMODIALYSIS
by: Javokhir Khalmukhamedov, et al.
Published: (2025-02-01)